Trial Site Detail

 

Drug:
Temozolomide
Trial:
Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

Dana Farber Cancer Institute

450 Brookline Ave     
Boston , MA 02215-5450
USA

 

Principal Investigator:
George Demetri, MD
Contact:
Tarsha Huftalen, RN, BSN 617-632-5117 tmhuftalen@partners.org
Activation Status of this Site:
Active
Notes about this Site:
Dana Farber Cancer Institute Website:
http://www.dana-farber.org/Research/Clinical-Trials.aspx

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.